| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5661333 | Pancreatology | 2016 | 7 Pages |
Abstract
Serum WFA+-M2BP can be a useful biomarker for the diagnosis of PDAC and the prediction of disease progression since it potentially reflects altered pro-oncologic glycosylation enzymes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Yuichi Waragai, Rei Suzuki, Tadayuki Takagi, Mitsuru Sugimoto, Hiroyuki Asama, Ko Watanabe, Hitomi Kikuchi, Takuto Hikichi, Atsushi Masamune, Ya'an Kang, Jason B. Fleming, Hiromasa Ohira,